Effect of B-Type Natriuretic Peptide Level on Long-Term Outcome in Patients With End-Stage Heart Failure

American Journal of Cardiology

Volumn 118, Issue 3, 2016, Pages 383-388

  Huang, Bi ^a   Shen, Jian ^a   Li, Lihua ^a   Huang, Ying ^a   Luo, Suxin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

ADULT; ALL CAUSE MORTALITY; ARTICLE; CHINA; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; END STAGE HEART FAILURE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MORTALITY RISK; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; CAUSE OF DEATH; HOSPITALIZATION; MORTALITY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; BIOMARKERS; CARDIOMYOPATHY, DILATED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORTALITY; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84971612060     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.05.018     Document Type: Article

References (26)

1. Ambrosy, A.P., Fonarow, G.C., Butler, J., Chioncel, O., Greene, S.J., Vaduganathan, M., Nodari, S., Lam, C.S., Sato, N., Shah, A.N., Gheorghiade, M., The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63 (2014), 1123–1133.
2. McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Ronnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33 (2012), 1787–1847.
3. Maisel, A.S., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Duc, P., Omland, T., Storrow, A.B., Abraham, W.T., Wu, A.H., Clopton, P., Steg, P.G., Westheim, A., Knudsen, C.W., Perez, A., Kazanegra, R., Herrmann, H.C., McCullough, P.A., Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002), 161–167.
4. Rahimi, K., Bennett, D., Conrad, N., Williams, T.M., Basu, J., Dwight, J., Woodward, M., Patel, A., McMurray, J., MacMahon, S., Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail 2 (2014), 440–446.
5. van Veldhuisen, D.J., Linssen, G.C., Jaarsma, T., van Gilst, W.H., Hoes, A.W., Tijssen, J.G., Paulus, W.J., Voors, A.A., Hillege, H.L., B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 61 (2013), 1498–1506.
6. Miller, W.L., Burnett, J.J., Hartman, K.A., Henle, M.P., Burritt, M.F., Jaffe, A.S., Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol 96 (2005), 837–841.
7. Sun, T., Wang, L., Zhang, Y., Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure. Intern Med J 37 (2007), 168–171.
8. Kemperman, H., van den Berg, M., Kirkels, H., de Jonge, N., B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device. Clin Chem 50 (2004), 1670–1672.
9. Jiang, H., Ge, J., Epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart 95 (2009), 1727–1731.
10. Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J.J., Ponikowski, P., Poole-Wilson, P.A., Stromberg, A., van Veldhuisen, D.J., Atar, D., Hoes, A.W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S.G., Swedberg, K., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29 (2008), 2388–2442.
11. Skrabal, F., Pichler, G.P., Gratze, G., Holler, A., Adding “hemodynamic and fluid leads” to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation. Med Eng Phys 36 (2014), 896–904 896.
12. de Lemos, J.A., McGuire, D.K., Drazner, M.H., B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003), 316–322.
13. Fonarow, G.C., Peacock, W.F., Phillips, C.O., Givertz, M.M., Lopatin, M., Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49 (2007), 1943–1950.
14. Oremus, M., Don-Wauchope, A., McKelvie, R., Santaguida, P.L., Hill, S., Balion, C., Booth, R., Brown, J.A., Ali, U., Bustamam, A., Sohel, N., Raina, P., BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev 19 (2014), 471–505.
15. Lourenco, P., Ribeiro, A., Pintalhao, M., Silva, S., Bettencourt, P., Predictors of six-month mortality in BNP-matched acute heart failure patients. Am J Cardiol 116 (2015), 744–748.
16. Vodovar, N., Seronde, M.F., Laribi, S., Gayat, E., Lassus, J., Boukef, R., Nouira, S., Manivet, P., Samuel, J.L., Logeart, D., Ishihara, S., Cohen, S.A., Januzzi, J.J., Richards, A.M., Launay, J.M., Mebazaa, A., Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur Heart J 35 (2014), 3434–3441.
17. Yandle, T.G., Richards, A.M., B-type natriuretic peptide circulating forms: analytical and bioactivity issues. Clin Chim Acta 448 (2015), 195–205.
18. Seferian, K.R., Tamm, N.N., Semenov, A.G., Tolstaya, A.A., Koshkina, E.V., Krasnoselsky, M.I., Postnikov, A.B., Serebryanaya, D.V., Apple, F.S., Murakami, M.M., Katrukha, A.G., Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 54 (2008), 866–873.
19. Rosjo, H., Dahl, M.B., Jorgensen, M., Roysland, R., Brynildsen, J., Cataliotti, A., Christensen, G., Hoiseth, A.D., Hagve, T.A., Omland, T., Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study. Clin Chem 61 (2015), 1087–1097.
20. Tremblay-Gravel, M., Khairy, P., Roy, D., Leduc, H., Wyse, D.G., Cadrin-Tourigny, J., Macle, L., Dubuc, M., Andrade, J., Rivard, L., Guerra, P.G., Thibault, B., Ahmed, A., Talajic, M., Guertin, M.C., White, M., Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studies. Eur J Heart Fail 16 (2014), 1168–1174.
21. Curtis, J.P., Sokol, S.I., Wang, Y., Rathore, S.S., Ko, D.T., Jadbabaie, F., Portnay, E.L., Marshalko, S.J., Radford, M.J., Krumholz, H.M., The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 42 (2003), 736–742.
22. Zorlu, A., Yilmaz, M.B., Yucel, H., Bektasoglu, G., Refiker, E.M., Tandogan, I., Increased D-dimer levels predict cardiovascular mortality in patients with systolic heart failure. J Thromb Thrombolysis 33 (2012), 322–328.
23. Chatterjee, S., Biondi-Zoccai, G., Abbate, A., D'Ascenzo, F., Castagno, D., Van Tassell, B., Mukherjee, D., Lichstein, E., Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ, 346, 2013, f55.
24. Marcucci, R., Gori, A.M., Giannotti, F., Baldi, M., Verdiani, V., Del, P.S., Nozzoli, C., Abbate, R., Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemost 4 (2006), 1017–1022.
25. Minami, Y., Haruki, S., Jujo, K., Itani, R., Shimazaki, K., Arashi, H., Watanabe, E., Hagiwara, N., Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure. Int J Cardiol 204 (2016), 42–44.
26. Jafri, S.M., Hypercoagulability in heart failure. Semin Thromb Hemost 23 (1997), 543–545.